SQRX — Squarex Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesMicro Cap
Annual cashflow statement for Squarex Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.681 | -0.364 | -0.556 |
| Depreciation | |||
| Non-Cash Items | 0.306 | 0.056 | 0.011 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.091 | 0.125 | 0.205 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -0.279 | -0.183 | -0.34 |
| Financing Cash Flow Items | — | — | 0.217 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.269 | 0.214 | 0.31 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.01 | 0.031 | -0.03 |